Patents by Inventor Gregor Schurmann

Gregor Schurmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10272132
    Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: April 30, 2019
    Assignee: Ra Pharmaceuticals, Inc.
    Inventors: Zhaolin Wang, Ping Ye, Alonso Ricardo, Kristopher Josephson, Paul Anderson, Michelle Denise Hoarty, Zhong Ma, Nathan Ezekiel Nims, Eberhard Schneider, Gregor Schurmann, Peter Wagner, Douglas A. Treco, Hong Zheng, Daniel Elbaum, Nicolas Cedric Boyer
  • Publication number: 20180256672
    Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.
    Type: Application
    Filed: May 14, 2018
    Publication date: September 13, 2018
    Inventors: Zhaolin Wang, Ping Ye, Alonso Ricardo, Kristopher Josephson, Paul Anderson, Michelle Denise Hoarty, Zhong Ma, Nathan Ezekiel Nims, Eberhard Schneider, Gregor Schurmann, Peter Wagner, Douglas A. Treco, Hong Zheng, Daniel Elbaum, Nicolas Cedric Boyer
  • Patent number: 9999650
    Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.
    Type: Grant
    Filed: March 15, 2017
    Date of Patent: June 19, 2018
    Assignee: Ra Pharmaceuticals, Inc.
    Inventors: Zhaolin Wang, Ping Ye, Alonso Ricardo, Kristopher Josephson, Paul Anderson, Michelle Denise Hoarty, Zhong Ma, Nathan Ezekiel Nims, Eberhard Schneider, Gregor Schurmann, Peter Wagner, Douglas A. Treco, Hong Zheng, Daniel Elbaum, Nicolas Cedric Boyer
  • Publication number: 20170189470
    Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.
    Type: Application
    Filed: March 15, 2017
    Publication date: July 6, 2017
    Inventors: Zhaolin Wang, Ping Ye, Alonso Ricardo, Kristopher Josephson, Paul Anderson, Michelle Denise Hoarty, Zhong Ma, Nathan Ezekiel Nims, Eberhard Schneider, Gregor Schurmann, Peter Wagner, Douglas A. Treco, Hong Zheng, Daniel Elbaum, Nicolas Cedric Boyer
  • Patent number: 9644004
    Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: May 9, 2017
    Assignee: Ra Pharmaceuticals, Inc.
    Inventors: Zhaolin Wang, Ping Ye, Alonso Ricardo, Kristopher Josephson, Paul Anderson, Michelle Denise Arata, Zhong Ma, Nathan Ezekiel Nims, Eberhard Schneider, Gregor Schurmann, Peter Wagner, Douglas A. Treco, Hong Zheng, Daniel Elbaum, Nicolas Cedric Boyer
  • Publication number: 20160251400
    Abstract: Disclosed are methods for identifying high affinity adaptor molecules that bind to both a circulating antibody and a target molecule and redirect the specificity of the circulating antibody to the target molecule. Exemplary high affinity adaptor molecules are also provided.
    Type: Application
    Filed: February 2, 2016
    Publication date: September 1, 2016
    Inventors: Albert Collinson, Peter Wagner, Matti Sallberg, Anders Vahlne, Gregor Schurmann, Robert Kamen
  • Publication number: 20160083430
    Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.
    Type: Application
    Filed: December 8, 2015
    Publication date: March 24, 2016
    Inventors: Zhaolin Wang, Ping Ye, Alonso Ricardo, Kristopher Josephson, Paul Anderson, Michelle Denise Arata, Zhong Ma, Nathan Ezekiel Nims, Eberhard Schneider, Gregor Schurmann, Peter Wagner, Douglas A. Treco, Hong Zheng, Daniel Elbaum, Nicolas Cedric Boyer
  • Patent number: 9238676
    Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: January 19, 2016
    Assignee: RA PHARMACEUTICALS, INC.
    Inventors: Zhaolin Wang, Ping Ye, Alonso Ricardo, Kristopher Josephson, Paul Anderson, Michelle Denise Arata, Zhong Ma, Nathan Ezekiel Nims, Eberhard Schneider, Gregor Schurmann, Peter Wagner, Douglas A. Treco, Hong Zheng, Daniel Elbaum, Nicolas Cedric Boyer
  • Publication number: 20150166606
    Abstract: The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.
    Type: Application
    Filed: March 14, 2013
    Publication date: June 18, 2015
    Inventors: Zhaolin Wang, Ping Ye, Alonso Ricardo, Kristopher Josephson, Paul Anderson, Michelle Denise Arata, Zhong Ma, Nathan Ezekiel Nims, Eberhard Schneider, Gregor Schurmann, Peter Wagner, Douglas A. Treco, Hong Zheng, Daniel Elbaum, Nicolas Cedric Boyer
  • Patent number: 8455614
    Abstract: Peptides are provided that have binding affinity for polymethyl methacrylate (PMMA). The polymethyl methacrylate-binding peptides may be used to prepare peptide-based reagents suitable for use in a variety of applications. The peptide-based reagents may be used to couple benefit agents to a PMMA polymer surface or may be used to couple a benefit agent comprising a PMMA polymer surface to a target surface, such as a body surface.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: June 4, 2013
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Eberhard Schneider, Gregor Schurmann, Peter Wagner, Hong Wang
  • Patent number: 8404214
    Abstract: Peptides are provided that have binding affinity for polymethyl methacrylate (PMMA). The polymethyl methacrylate-binding peptides may be used to prepare peptide-based reagents suitable for use in a variety of applications. The peptide-based reagents may be used to couple benefit agents to a PMMA polymer surface or may be used to couple a benefit agent comprising a PMMA polymer surface to a target surface, such as a body surface.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: March 26, 2013
    Assignee: E I du Pont de Nemours and Company
    Inventors: Eberhard Schneider, Gregor Schurmann, Peter Wagner, Hong Wang
  • Patent number: 8389675
    Abstract: Peptides are provided that have binding affinity for polymethyl methacrylate (PMMA). The polymethyl methacrylate-binding peptides may be used to prepare peptide-based reagents suitable for use in a variety of applications. The peptide-based reagents may be used to couple benefit agents to a PMMA polymer surface or may be used to couple a benefit agent comprising a PMMA polymer surface to a target surface, such as a body surface.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: March 5, 2013
    Assignee: E I du Pont de Nemours and Company
    Inventors: Eberhard Schneider, Gregor Schurmann, Peter Wagner, Hong Wang
  • Patent number: 8378065
    Abstract: Peptides are provided that have binding affinity for polymethyl methacrylate (PMMA). The polymethyl methacrylate-binding peptides may be used to prepare peptide-based reagents suitable for use in a variety of applications. The peptide-based reagents may be used to couple benefit agents to a PMMA polymer surface or may be used to couple a benefit agent comprising a PMMA polymer surface to a target surface, such as a body surface.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: February 19, 2013
    Assignee: E I du Pont de Nemours and Company
    Inventors: Eberhard Schneider, Gregor Schurmann, Peter Wagner, Hong Wang
  • Publication number: 20130011356
    Abstract: Hair-binding peptides were isolated for their use in a variety of personal care formulations and applications. The isolation of hair-binding peptides was accomplished by enrichment using mRNA-display selection technology. Hair care compositions comprising peptide-based reagents prepared comprising the hair-binding peptides are also provided.
    Type: Application
    Filed: September 13, 2012
    Publication date: January 10, 2013
    Applicant: E I DU PONT DE NEMOURS AND COMPANY
    Inventors: Stephen R. Fahnestock, Eberhard Schneider, Gregor Schurmann, Peter Wagner
  • Patent number: 8287845
    Abstract: Hair-binding peptides were isolated for their use in a variety of personal care formulations and applications. The isolation of hair-binding peptides was accomplished by enrichment using mRNA-display selection technology. Hair care compositions comprising peptide-based reagents prepared comprising the hair-binding peptides are also provided.
    Type: Grant
    Filed: December 2, 2009
    Date of Patent: October 16, 2012
    Assignee: E I du Pont de Nemours and Company
    Inventors: Stephen R. Fahnestock, Eberhard Schneider, Gregor Schurmann, Peter Wagner
  • Patent number: 8263737
    Abstract: Peptides are provided that have binding affinity for polymethyl methacrylate (PMMA). The polymethyl methacrylate-binding peptides may be used to prepare peptide-based reagents suitable for use in a variety of applications. The peptide-based reagents may be used to couple benefit agents to a PMMA polymer surface or may be used to couple a benefit agent comprising a PMMA polymer surface to a target surface, such as a body surface.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: September 11, 2012
    Assignee: E I du Pont de Nemours and Company
    Inventors: Eberhard Schneider, Gregor Schurmann, Peter Wagner, Hong Wang
  • Patent number: 8206693
    Abstract: Peptides are provided that have binding affinity for polymethyl methacrylate (PMMA). The polymethyl methacrylate-binding peptides may be used to prepare peptide-based reagents suitable for use in a variety of applications. The peptide-based reagents may be used to couple benefit agents to a PMMA polymer surface or may be used to couple a benefit agent comprising a PMMA polymer surface to a target surface, such as a body surface.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: June 26, 2012
    Assignee: E I du Pont de Nemours and Company
    Inventors: Eberhard Schneider, Gregor Schurmann, Peter Wagner, Hong Wang
  • Publication number: 20100310495
    Abstract: Peptides are provided that have binding affinity for poly(benzyl methacrylate-co-methacrylic acid) potassium salt copolymers (“BzMA-binding peptides”). The BzMA-binding peptides may be used to prepare peptide-based reagents suitable for use in a variety of applications. The peptide-base reagents may be used to couple benefit agents to a poly(benzyl methacrylate-co-methacrylic acid) potassium salt copolymer surface or may be used to couple a benefit agent comprising a poly(benzyl methacrylate-co-methacrylic acid) potassium salt copolymer surface to a target surface, such as a body surface.
    Type: Application
    Filed: May 24, 2010
    Publication date: December 9, 2010
    Applicant: E. I. DU PONT DE NEMOURS AND COMPANY
    Inventors: EBERHARD SCHNEIDER, GREGOR SCHURMANN, PETER WAGNER, HONG WANG, GORDON MARK COHEN
  • Publication number: 20100298533
    Abstract: Peptides are provided that have binding affinity for polymethyl methacrylate (PMMA). The polymethyl methacrylate-binding peptides may be used to prepare peptide-based reagents suitable for use in a variety of applications. The peptide-based reagents may be used to couple benefit agents to a PMMA polymer surface or may be used to couple a benefit agent comprising a PMMA polymer surface to a target surface, such as a body surface.
    Type: Application
    Filed: May 12, 2010
    Publication date: November 25, 2010
    Applicant: E.I. DU PONT DE NEMOURS AND COMPANY
    Inventors: Eberhard Schneider, Gregor Schurmann, Peter Wagner, Hong Wang
  • Publication number: 20100298231
    Abstract: Peptides are provided that have binding affinity for polymethyl methacrylate (PMMA). The polymethyl methacrylate-binding peptides may be used to prepare peptide-based reagents suitable for use in a variety of applications. The peptide-based reagents may be used to couple benefit agents to a PMMA polymer surface or may be used to couple a benefit agent comprising a PMMA polymer surface to a target surface, such as a body surface.
    Type: Application
    Filed: May 12, 2010
    Publication date: November 25, 2010
    Applicant: E. I. DU PONT DE NEMOURS AND COMPANY
    Inventors: EBERHARD SCHNEIDER, Gregor Schurmann, Peter Wagner, Hong Wang